Anticancer drugs need to be more responsibility

Custom Synthesis, In recent years, the incidence of cancer patients in China has been increasing, anticancer drug market is becoming more and more extensive.

The reason why the import of anticancer drugs to reduce tariff rates has attracted market attention, on the one hand, because cancer treatment drugs in China are mainly dependent on imports, on the other hand, because the price of cancer treatment drugs is higher, people expect the country to reduce prices through various measures. Prime Minister Li Keqiang offered a zero-tariff policy on the importation of anticancer drugs, allowing people to see the hope and possibility of using imported anti-cancer drugs. However, it is worth mentioning that the anticancer drug itself, the price is higher, a patient a year’s cost of a hundred thousand of yuan or even hundreds of thousands of yuan.

Such anticancer drugs, even if the imposition of a zero tariff rate, the price drop is also difficult to benefit most people. How to enhance the accessibility of people’s medication? The author believes that in addition to reducing the tariff rate of imported drugs, we should also take various measures to urge the price of drugs, in the field of anticancer drug treatment, Chinese pharmaceutical companies should play a more important role.